TickerFacts.

Neurogene Inc. (NGNE): Shares Outstanding

Annual figures by period end, from SEC filings.

Stock splits: 1-for-5, first reflected in a filing dated 2023-11-14. Figures are as filed: per-share figures and share counts last reported before a split are on the old share basis, so changes and growth rates across a split are not shown. Splits are read from the filings' own restatements, so a share conversion in a merger or reorganization shows up the same way.

15.49M
As of 2025-12-31
15.83M
As of 2026-06-30
42.65M2013-12-31: 301.7K2014-12-31: 10.70M2015-12-31: 17.21M2016-12-31: 23.42M2017-12-31: 23.47M2018-12-31: 23.54M2019-12-31: 38.00M2020-12-31: 42.20M2021-12-31: 42.46M2022-12-31: 42.65M2023-12-31: 12.82M2024-12-31: 14.85M2025-12-31: 15.49M15.49M
2013-12-31 Shares Outstanding (shares) 2025-12-31

Paler bars were last filed before a stock split, on the old share basis.

Period endedShares OutstandingChange YoYSource filing
2025-12-3115.49M+4.3%2026-03-24, Balance as of period end
2024-12-3114.85M+15.8%2026-03-24, Balance as of period end
2023-12-3112.82Mn/c2025-03-24, Balance as of period end
2022-12-3142.65M+0.4%2023-03-20, Balance as of period end
2021-12-3142.46M+0.6%2023-03-20, Balance as of period end
2020-12-3142.20M+11.1%2022-03-01, Balance as of period end
2019-12-3138.00M+61.4%2021-03-25, Balance as of period end
2018-12-3123.54M+0.3%2020-03-12, Balance as of period end
2017-12-3123.47M+0.2%2019-03-07, Balance as of period end
2016-12-3123.42M+36.1%2018-03-12, Balance as of period end
2015-12-3117.21M+60.9%2017-03-09, Balance as of period end
2014-12-3110.70Mn/m2016-03-14, Balance as of period end
2013-12-31301.7Kn/a2015-03-16, Balance as of period end